Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with increased risk of neonatal morbidity. The use of BF% as an alternative to birth weight percentiles may provide additional information regarding undernutrition in newborns. Further studies are required to assess whether BF% is a better predictor of neonatal morbidity than birth weight percentiles. Our data suggest that BF% should be considered alongside birth weight percentiles when evaluating nutritional status in newborns. However, the relationship between BF% and birth weight percentiles needs further investigation. This may allow clinicians to make more accurate predictions of neonatal morbidity based on both measures of nutritional status. Future studies should also explore the impact of different gestational ages on these relationships.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant’s reply is generally accurate and cautious: it correctly states that low BF% is associated with higher neonatal morbidity and that BF% can add information beyond birth weight percentiles. However it is overly equivocal given the study results — the study found BF% was more closely associated with neonatal morbidity (higher OR) and identified undernourished neonates who would be missed by birth weight percentiles. The response omits these specific findings and introduces unnecessary speculation (gestational-age effects) despite the study including term infants only. Overall the answer is correct but incomplete and understates the study’s conclusion.

conciseness: 0.5
Reasoning:
The response correctly notes that low BF% is associated with increased neonatal morbidity and that BF% can add information beyond birth weight percentiles, but it is verbose and repetitive and avoids a clear, direct answer despite the study data supporting that BF% is more closely associated with risk. It also adds calls for further study that, while reasonable, repeat the same point multiple times instead of succinctly stating the study's implication.

relevance: 0.5
Reasoning:
The assistant's reply is generally relevant — it acknowledges that low BF% is associated with higher neonatal morbidity and recommends considering BF% alongside birth weight percentiles. However, it is overly cautious given the study results (which showed a stronger association for BF% than for birth weight percentiles) and does not explicitly state that BF% performed better in this population nor cite the study's findings or a direct quote. It also introduces an extraneous suggestion about varying gestational ages despite the study being limited to term neonates. 

coherence: 0.7
Reasoning:
The response is generally coherent and well organized: it states the key association (low BF% linked to higher neonatal morbidity), compares BF% with birth weight percentiles, and gives practical advice (consider BF% alongside birth weight percentiles) while noting the need for further study. However, it is somewhat cautious and repetitive and stops short of directly answering whether BF% is definitively "better" despite the study data suggesting stronger association; thus it could be clearer and more decisive in summarizing the study’s implication.

helpfulness: 0.5
Reasoning:
The assistant correctly notes that low BF% is associated with increased neonatal morbidity and that BF% can add information beyond birth weight percentiles. However, it is overly cautious and fails to state the study's main finding: BF% was more strongly associated with neonatal morbidity than birth weight percentiles (higher OR), and that BF% can identify undernourished infants who appear appropriately grown and exclude small infants not at risk. The reply is therefore partially helpful but omits key results and actionable conclusion from the study.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The diagnosis of ischemic Charcot foot is an important issue, especially when it is associated with diabetes mellitus, as it can lead to a high risk of complications such as infections, ulcers, gangrene, loss of sensation, atrophy of muscles and bones, deformity and disability. Despite the advances in the treatment of Charcot neuroarthropathy, there are still controversies regarding its treatment and the best approach to avoid the risk of amputation. In this study we report on the results of 10 cases of ischemic Charcot foot treated with endovascular revascularization, surgical debridement and orthopedic correction. We believe that this treatment may be useful in the treatment of ischemic Charcot foot. Further studies are needed to confirm these results.
It seems that the best option for the management of ischemic Charcot foot is the multidisciplinary approach based on the use of surgery and vascular surgery techniques. It would be interesting to compare the results of this study with other similar studies that have been conducted. This would help to determine whether this is the most effective treatment for this condition. Further studies are also necessary to assess the long-term efficacy of this treatment.
The results of this study show that the use of endovascular revascularization followed by surgical and orthopedic correction is an effective way to treat ischemic Charcot foot. However, the risk of infection remains high. It would be interesting to investigate the possibility of using antibiotic prophylaxis before and during the surgical procedures.
Our experience suggests that the use of endovascular revascularization combined with surgical and orthopedic correction is a good option for treating ischemic Charcot foot. However, further studies are necessary to confirm these results. Moreover, this treatment should be considered only in selected cases where the risk of amputation is high.
In conclusion, the results of this study suggest that the use of endovascular revascularization followed by surgical and orthopedic correction is safe and effective for treating ischemic Charcot foot. However, the risk of infection remains high and further studies are necessary to assess the long-term efficacy of this procedure.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.8
Reasoning:
The assistant's reply is largely correct and consistent with the ground truth: it recognizes ischemic Charcot foot as a situation that benefits from revascularization plus surgical/orthopedic care and advocates a multidisciplinary approach to improve limb salvage. However the answer is somewhat repetitive, non-specific (it does not explicitly state that ischemic Charcot foot requires different/additional vascular treatment compared with non‑ischemic Charcot foot), and it omits the study's key numerical outcomes and limitations that would strengthen the conclusion.

conciseness: 0.3
Reasoning:
The assistant's reply is wordy and repetitive, and it fails to directly answer the posed question (whether ischemic Charcot foot is a distinct disease requiring different treatment). It reiterates that a multidisciplinary approach including endovascular revascularization plus surgical/orthopedic treatment may be useful, but omits key study outcomes (limb salvage rate, healing time) and does not clearly state whether treatment should differ from non-ischemic Charcot foot. Overall, the response is not concise or to the point.

relevance: 0.5
Reasoning:
The assistant's reply is generally relevant: it addresses the question by stating that ischemic Charcot foot is best managed with a multidisciplinary approach that includes endovascular revascularization plus surgical and orthopedic treatment. It correctly draws on the study described in the context (10 cases) and concludes that revascularization-supported care can help avoid amputation. However, the response fails to cite key specific data from the context (for example the 90% limb salvage rate and mean healing time ~197 days), is somewhat repetitive, and does not explicitly state whether ischemic Charcot foot should be considered a distinct disease entity with a different treatment pathway — it implies this but does not clearly answer that part. It also lacks any direct quotation from the provided text.

coherence: 0.5
Reasoning:
The response is generally coherent and organized: it restates the study context, advocates a multidisciplinary approach (endovascular revascularization plus surgical/orthopedic care), and concludes with cautious recommendations for further study. However, it is repetitive, vague, and does not directly answer the posed question — whether ischemic Charcot foot is a different disease that requires different treatment — nor does it use the provided outcome data (90% limb salvage, mean healing time ~197 days) to support its conclusions. It also omits a clear comparison with non-ischemic Charcot management and offers speculative points (e.g., antibiotic prophylaxis) without justification. Overall, the answer is readable but lacks focus, specificity, and direct engagement with the question.

helpfulness: 0.6
Reasoning:
The assistant's reply is generally aligned with the ground truth in emphasizing that a multidisciplinary approach including endovascular revascularization plus surgical/orthopedic treatment can support limb salvage in ischemic Charcot foot. However, the answer is overly generic and repetitive, and it fails to cite the key study outcomes (e.g., 90% limb salvage, mean healing time ~197 days) or to directly state that ischemic Charcot represents a clinically distinct presentation that often requires revascularization as part of treatment. It also makes speculative suggestions (e.g., antibiotic prophylaxis) without evidence from the reported series and does not acknowledge the very small sample size, limiting generalizability. Overall the response is moderately helpful but lacks specificity and critical appraisal.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: We could not identify any significant difference in survival outcomes between the three types of hysterectomy used in the GOTIC-005 trial. Radical hysterectomy, mRH, and SH showed similar overall survival, progression-free survival, and postoperative complications. Although the RH group had longer operative times, higher rates of blood transfusions, and more severe urinary tract dysfunctions, these differences did not influence the survival outcomes. Therefore, RH may be unnecessary for patients with endometrial cancer with suspected cervical involvement. This finding needs to be further validated by larger studies. We suggest that physicians should consider the individual patient's condition when deciding on surgical treatment.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.6
Reasoning:
The assistant's answer correctly conveys the main result that radical hysterectomy (RH) showed no survival benefit over modified radical or simple hysterectomy in the GOTIC-005 cohort and appropriately notes longer operative time, higher transfusion rates, and more urinary dysfunction with RH and the need for further validation. However, it contains an internal contradiction and a factual inaccuracy: it first states that postoperative complications were similar across groups (incorrect), then later lists specific worse perioperative/late adverse events for RH (which matches the study). The reply also omits mention of the other identified independent prognostic factors (age, grade, peritoneal cytology, lymph node involvement). Overall the response is mostly accurate about survival findings but flawed in its statement about complications and incomplete in reporting prognostic factors.

conciseness: 0.6
Reasoning:
The response is concise and summarizes the main finding (no survival benefit of radical hysterectomy) and the clinical implication (consider individual patient factors; further validation needed). However it contains a contradiction/inaccuracy about complications: it first states postoperative complications were similar across groups, then notes RH had longer operative time, higher transfusion rates, and more severe urinary dysfunction — the first claim about similar complications is misleading given the documented higher perioperative and late adverse events with RH. Overall succinct but slightly imprecise.

relevance: 0.6
Reasoning:
The assistant's reply is relevant and addresses the study question directly, correctly stating that no survival benefit was found for radical hysterectomy and noting longer operative time, higher transfusion rates, and worse urinary dysfunction with RH. However, it incorrectly claims that postoperative complications were similar across groups — the context specifies perioperative and late adverse events were more frequent with RH. The answer appropriately recommends further studies and individualized decision-making but contains that factual inconsistency.

coherence: 0.6
Reasoning:
The assistant's reply is mostly coherent and summarizes the key finding (no survival benefit of radical hysterectomy) and the recommendation to individualize care and seek further study. However, it contains an internal contradiction: it first states that postoperative complications were similar across groups, then immediately notes that RH had longer operative time, higher transfusion rates, and more severe urinary dysfunction — which conflicts with the earlier claim and with the ground truth that RH had more perioperative and late adverse events. It also omits explicit mention that hysterectomy type was not an independent prognostic factor for local recurrence-free survival, though it covers overall and progression-free survival. Overall the response is organized and concise but marred by that inconsistency.

helpfulness: 0.6
Reasoning:
The assistant gave a concise, mostly accurate summary and correctly emphasized the main point that radical hysterectomy (RH) showed no survival benefit and was associated with longer operative time, more transfusions, and more urinary dysfunction — and that findings warrant further study. However, it incorrectly stated that postoperative complications were similar across groups (the ground truth notes more perioperative and late adverse events with RH), and it omitted that multivariable analysis identified age, grade, peritoneal cytology, and lymph node status — not hysterectomy type — as independent prognostic factors. Overall helpful but contains a factual inaccuracy and a notable omission.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are predictable by preoperative factors, including pancreatic fistula, multivisceral resections, and prolonged hospital stay. Perioperative factors include length of stay, ICU admission, and postoperative complications such as ileus and delayed gastric emptying. Postoperative complications may lead to delayed readmissions, which should be anticipated during the first 7 days. Therefore, proactive measures to prevent or treat these complications should be considered. Proper patient selection, enhanced perioperative care, and improved communication among providers will help reduce the likelihood of readmissions. A prospective study design would allow further exploration of the risk factors for readmissions and their potential impact on outcomes. Additionally, strategies aimed at reducing readmissions could be implemented in the current practice setting. These interventions should focus on improving the care of high-risk patients, optimizing surgical technique, and improving the postoperative management of patients who require readmission. Prospective evaluation of these strategies would be necessary to determine their effectiveness in reducing readmissions. Future studies should also examine the impact of readmissions on cost, quality, and survival. To minimize readmissions, it is essential to address the underlying factors that lead to them. Identifying and treating patients who are at risk of readmission is an important step toward improving the quality of care provided. Strategies to enhance patient education and optimize communication among providers may help reduce the need for readmissions. Furthermore, incorporation of evidence-based best practices into the standard operating procedures of hospitals may improve the quality of care delivered. Finally, regular audits and assessment of quality metrics will facilitate improvement in patient outcomes.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.5
Reasoning:
The assistant's answer lists many of the correct predictors of readmission after PD (pancreatic fistula, multivisceral resection, prolonged initial stay, ICU admission) and suggests reasonable prevention strategies and the need for prospective evaluation. However, it contains factual/imprecise statements (e.g., calling pancreatic fistula a "preoperative" factor and conflating “delayed readmissions” with events in the first 7 days), and it fails to highlight the key finding that about 50% of readmissions occur within 7 days and that efforts should especially target preventing these early readmissions. Overall the response is generally relevant but has important inaccuracies and omissions.

conciseness: 0.4
Reasoning:
The response lists relevant risk factors (pancreatic fistula, multivisceral resection, prolonged LOS, ICU admission, ileus, delayed gastric emptying) and suggests reasonable interventions (patient selection, perioperative care, communication, audits). However it is somewhat repetitive and imprecise (it incorrectly frames pancreatic fistula as a “preoperative” factor, and it does not clearly emphasize the key ground-truth point that half of readmissions occur within 7 days and that preventing early readmissions should be a central focus). Overall the answer is longer than necessary and lacks the concise, targeted recommendation to prioritize prevention of early readmissions.

relevance: 0.6
Reasoning:
The assistant’s reply is partially relevant: it correctly cites several predictors from the context (pancreatic fistula, multivisceral/complex resection, prolonged initial stay, ICU admission, and early postoperative problems such as ileus and delayed gastric emptying) and recommends sensible prevention strategies (patient selection, perioperative care, communication, targeted high‑risk management). However, it contains an internal inconsistency ("postoperative complications may lead to delayed readmissions, which should be anticipated during the first 7 days") that contradicts the context’s distinction between early (≤7 days) and late (>7 days) readmissions. The recommendations are also fairly general and do not explicitly restate the context’s key conclusion that efforts should be centered on preventing early readmissions, which account for half of all readmissions.

coherence: 0.6
Reasoning:
The assistant's reply is generally organized — it lists risk factors, timing, and preventive strategies and suggests prospective evaluation — so it reads coherently. However, it contains factual and logical problems (e.g., calling pancreatic fistula a "preoperative" predictor, some contradictory wording about timing of complications/readmissions, and vague, repetitive recommendations). It also fails to emphasize the paper's key point that early (≤7 day) readmissions account for about half of readmissions and should be a primary prevention target.

helpfulness: 0.6
Reasoning:
The response is partially helpful: it correctly identifies several predictors of readmission after PD (pancreatic fistula, multivisceral resection/complex initial resection, prolonged LOS, ICU admission, and common complications such as ileus and delayed gastric emptying) and offers reasonable broad strategies (better perioperative care, patient selection, communication, and targeting high‑risk patients). However, it is somewhat generic, omits key quantitative findings (15% overall readmission rate; 50% of readmissions occur within 7 days) and does not emphasize the ground‑truth conclusion that efforts should particularly target early (≤7 day) readmissions. It also contains a confusing statement about “postoperative complications may lead to delayed readmissions, which should be anticipated during the first 7 days,” which conflates early versus late timing. More specific, evidence‑based prevention measures (early postdischarge follow‑up, targeted fistula prevention/management, standardized discharge protocols, outpatient support) would make the answer more actionable.

================================================================================
Average correctness Score: 0.52
Average conciseness Score: 0.395
Average relevance Score: 0.53
Average coherence Score: 0.53
Average helpfulness Score: 0.495
